Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergetic delivery of triptolide and Ce6 with light-activatable liposomes for efficient hepatocellular carcinoma therapy
Authors
Keywords
Hepatocellular carcinoma, Synergetic delivery, Triptolide, Ce6, Photo-activatable liposomes, Photosensitizer, Process of photodynamic therapy, PDX model
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-02-06
DOI
10.1016/j.apsb.2021.02.001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The landscape of gene mutations in cirrhosis and hepatocellular carcinoma
- (2020) Miryam Müller et al. JOURNAL OF HEPATOLOGY
- Synergistic Platinum(II) Prodrug Nanoparticles for Enhanced Breast Cancer Therapy
- (2020) Chen-Xi Yang et al. MOLECULAR PHARMACEUTICS
- A new perspective of triptolide-associated hepatotoxicity: the relevance of NF-κB and NF-κB-mediated cellular FLICE-inhibitory protein
- (2020) Ziqiao Yuan et al. Acta Pharmaceutica Sinica B
- Delivery of triptolide with reduction-sensitive polymer nanoparticles for liver cancer therapy on patient-derived xenografts models
- (2020) Mengxue He et al. CHINESE CHEMICAL LETTERS
- Transforming a toxic drug into an efficacious nanomedicine using a lipoprodrug strategy for the treatment of patient-derived melanoma xenografts
- (2020) Linlin Shi et al. JOURNAL OF CONTROLLED RELEASE
- Clinical development and potential of photothermal and photodynamic therapies for cancer
- (2020) Xingshu Li et al. Nature Reviews Clinical Oncology
- Recent advances in delivery of photosensitive metal-based drugs
- (2019) Yingjie Yu et al. COORDINATION CHEMISTRY REVIEWS
- Recent advance in polymer based microspheric systems for controlled protein and peptide delivery
- (2019) Yuanyuan Yang et al. CURRENT MEDICINAL CHEMISTRY
- A novel mitochondria-targeting tetrapeptide for subcellular delivery of nanoparticles
- (2019) Yanhui Sun et al. CHINESE CHEMICAL LETTERS
- Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
- (2019) Xiaopin Duan et al. Nature Communications
- Injectable peptide hydrogel as intraperitoneal triptolide depot for the treatment of orthotopic hepatocellular carcinoma
- (2019) Xiyue Zhao et al. Acta Pharmaceutica Sinica B
- Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy
- (2019) Yongbing Sun et al. Asian Journal of Pharmaceutical Sciences
- A Cell Membrane‐Targeting Self‐Delivery Chimeric Peptide for Enhanced Photodynamic Therapy and In Situ Therapeutic Feedback
- (2019) Wen Ma et al. Advanced Healthcare Materials
- TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages
- (2019) Zhipeng Liu et al. CANCER LETTERS
- Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance
- (2018) Qiling Chen et al. CHEMICAL COMMUNICATIONS
- Recent progress in polymer-based platinum drug delivery systems
- (2018) Haihua Xiao et al. PROGRESS IN POLYMER SCIENCE
- Stimuli-responsive nanotherapeutics for precision drug delivery and cancer therapy
- (2018) Yiting Qiao et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Synthesis, functionalization, and nanomedical applications of functional magnetic nanoparticles
- (2018) Zhou Chen et al. CHINESE CHEMICAL LETTERS
- Galactosylated chitosan Triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms
- (2018) Yan-Qiong Zhang et al. Nanomedicine-Nanotechnology Biology and Medicine
- External stimulus responsive inorganic nanomaterials for cancer theranostics
- (2018) Sheikh Mohamed M. et al. ADVANCED DRUG DELIVERY REVIEWS
- NQO1-Selective Activated Prodrug of Triptolide: Synthesis and Antihepatocellular Carcinoma Activity Evaluation
- (2018) Meilin Liu et al. ACS Medicinal Chemistry Letters
- Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma
- (2017) Jingxiong Lu et al. Small
- From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world
- (2017) Dimitrios Dimitroulis et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment
- (2017) Wanxian Luo et al. Theranostics
- Near-Infrared-Triggered Azobenzene-Liposome/Upconversion Nanoparticle Hybrid Vesicles for Remotely Controlled Drug Delivery to Overcome Cancer Multidrug Resistance
- (2016) Chi Yao et al. ADVANCED MATERIALS
- Two-photon excitation nanoparticles for photodynamic therapy
- (2016) Yizhong Shen et al. CHEMICAL SOCIETY REVIEWS
- Hepatocellular carcinoma: clinical frontiers and perspectives
- (2014) Jordi Bruix et al. GUT
- Triptolide: structural modifications, structure–activity relationships, bioactivities, clinical development and mechanisms
- (2012) Zhao-Li Zhou et al. NATURAL PRODUCT REPORTS
- Stimuli-responsive liposome-nanoparticle assemblies
- (2011) Matthew R Preiss et al. Expert Opinion on Drug Delivery
- Triptolide and its expanding multiple pharmacological functions
- (2011) Qiuyan Liu INTERNATIONAL IMMUNOPHARMACOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation